Van Wert, Ohio
July 23, 2007
Advance Biological Marketing (ABM) posted record sales at
the conclusion of their fiscal year, ending June 30.
Their success is due largely to Excalibre™, the most
technologically advanced soybean inoculant to hit the
marketplace. Excalibre now has a 120-day post-application
planting window. It was introduced to the industry in January
2006 with a 60-day, post-application planting window, which was
broadened to 120 days for the 2007 planting season.
“This is the first year that ABM sold our products through
distribution channels and we owe a great thanks to the regional
and national distributors who helped us achieve our growth and
success,” Dan Custis, ABM president, said. “ABM’s share of the
soybean inoculant market nearly doubled, despite a substantial
drop in U.S. soybeans planted in 2007.”
Excalibre is the only 120-day Bradyrhizobia and encapsulated
soybean inoculant available to date. With these enhancements and
longer shelf life, Excalibre provides agricultural seed dealers
and farmers significant advantages in handling, planting and
profitability.
ABM also enjoyed continued success with additional biological
products, according to Marty Robinson, ABM Vice President of
Sales and Marketing. “Our biological fungicide for wheat, T-22,
has become the most widely used EPA registered biofungicide in
U.S. field crops.”
Advanced Biological Marketing (ABM) is a Van Wert, Ohio based
marketer of specialty products for production agriculture in the
United States and Canada. The company’s products are some of the
most advanced technologies available today. ABM is committed to
educating its customers about the latest advances in
agriculture. It was founded in 2000 as a privately held schedule
C stock company, and is currently owned by more than 200
individual and institutional shareholders. |
|